Matthew C Cane Selected Research

Matthew C Cane Research Topics

3	Necrosis 01/2017 - 08/2014
3	Pancreatitis 01/2017 - 08/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 01/2016
1	Weight Gain 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014
1	Inflammation (Inflammations) 08/2014
1	Hemophilia A (Haemophilia) 02/2008

2	CalciumIBA 01/2017 - 01/2016
2	EnzymesIBA 01/2016 - 08/2014
1	Caffeine (No Doz)FDA LinkGeneric 01/2017
1	XanthinesIBA 01/2017
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Mitochondrial Permeability Transition PoreIBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Bile Acids and Salts (Bile Acids)IBA 01/2016
1	Choline (Choline Chloride)IBA 01/2016
1	Enzyme Precursors (Zymogens)IBA 01/2016
1	EthionineIBA 01/2016
1	Inositol (Myoinositol)IBA 01/2016
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Calcium Channels (Calcium Channel)IBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	CytokinesIBA 01/2016
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2016
1	EstersIBA 08/2014
1	fatty acyl ethyl ester synthaseIBA 08/2014
1	Carboxylesterase (Hydrolase S)IBA 08/2014
1	NAD (NADH)IBA 08/2014
1	Ethanol (Ethyl Alcohol)IBA 08/2014
1	4-methylpiperazine-2,6-dioneIBA 08/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2014
1	3-benzyl-6-chloro-2-pyroneIBA 08/2014
1	Proteins (Proteins, Gene)FDA Link 02/2008
1	Factor VIII (Coagulation Factor VIII)IBA 02/2008

1	Drug Therapy (Chemotherapy) 01/2016